Sartorius Aktiengesellschaft (FRA:SRT)
Market Cap | 14.43B |
Revenue (ttm) | 3.44B |
Net Income (ttm) | 95.60M |
Shares Out | n/a |
EPS (ttm) | n/a |
PE Ratio | 150.99 |
Forward PE | n/a |
Dividend | 0.73 (0.42%) |
Ex-Dividend Date | Mar 28, 2025 |
Volume | 22 |
Average Volume | 71 |
Open | 182.00 |
Previous Close | 178.20 |
Day's Range | 182.00 - 185.00 |
52-Week Range | 138.20 - 231.00 |
Beta | n/a |
RSI | 60.94 |
Earnings Date | Jul 22, 2025 |
About FRA:SRT
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy... [Read more]
Financial Performance
In 2024, FRA:SRT's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.
Financial StatementsNews
Sartorius Aktiengesellschaft (SARTF) Q1 2025 Earnings Call Transcript
Sartorius sends U.S. peers higher after Q1 2025 results
Sartorius AG (SARTF) Reports Strong Q1 Growth and Financial Improvements
Sartorius AG (SARTF) Reports Strong Q1 Growth and Financial Improvements
Sartorius Aktiengesellschaft Non-GAAP EPS of €1.23, revenue of €883M; initiates FY25 outlook
Sartorius Aktiengesellschaft press release (SARTF): Q1 Non-GAAP EPS of €1.23. Revenue of €883M (+7.7% Y/Y). Net operating cash flow tripled to 139 million euros, compared with 45 million

Sartorius Soars: Q1 Profits Surge with Strong Start
Sartorius kicked off 2025 with impressive growth, marking a 6.5% rise in sales revenue, driven by the robust performance of its Bioprocess Solutions division. Jetzt den vollständigen Artikel lesen

EQS-News: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter
EQS-News: SARTORIUS AG / Key word(s): Quarter Results/Forecast Strong start to the year: Sartorius achieves significant profitable growth in the first quarter (news with additional features) 16.04.202...

Sartorius Vz. Expands with MatTek Acquisition from BICO AB
Sartorius AG is poised to expand its horizons with the strategic acquisition of MatTek Corp and Visikol Inc. This move promises to bolster Sartorius' cell culture offerings with cutting-edge 3D microt...

EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB
EQS-News: SARTORIUS AG / Key word(s): Mergers & Acquisitions Sartorius to acquire microtissue business MatTek from Swedish BICO AB (news with additional features) 04.04.2025 / 18:00 CET/CEST The issue...

EQS-AFR: Sartorius AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: SARTORIUS AG / Preliminary announcement on the disclosure of financial statements Sartorius AG: Preliminary announcement of the publication of quarterly...

EQS-AFR: Sartorius AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: SARTORIUS AG / Preliminary announcement on the disclosure of financial statements Sartorius AG: Preliminary announcement of the publication of financial...

EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius
EQS-News: SARTORIUS AG / Key word(s): Sustainability First ISCC Plus certifications pave the way for renewable plastics at Sartorius (news with additional features) 31.03.2025 / 14:12 CET/CEST The iss...
Sartorius: Debt, Uncertainty, And Stock Plunge - Is It Still Overvalued?

Sartorius Aktiengesellschaft (SARTF) Q4 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q4 2024 Earnings Call January 28, 2025 7:00 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Florian Funck - Chief Financial Officer Re...

Betting on Growth: 4 Favorite Stocks From T. Rowe Price's Peter Bates
The manager of the Global Select Equity Strategy looks for high margins, cash generation, competitive advantages, and a long runway of growth.

Sartorius Aktiengesellschaft (SARTF) Q3 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q3 2024 Earnings Conference Call October 17, 2024 7:00 AM ET Company Participants Joachim Kreuzburg - Chairman René Fáber - Chief Executive Officer Florian F...

Sartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q1 2024 Earnings Conference Call April 18, 2024 7:00 AM ET Corporate Participants Dr. Joachim Kreuzburg - Chairman René Fáber - Chief Executive Officer Flori...

Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript

10 stocks for investors looking for ‘wonderful companies at a fair price'
As money managers talk about various methods of selecting quality companies, investors might also think about diversification, which can lower risk and broaden opportunities.

These 5 DAX index companies are in trouble as their stocks plunge
German stocks are not doing well as the economy goes through substantial challenges. The most recent data showed that business confidence has tumbled while manufacturing and services PMIs have remaine...

Sartorius Aktiengesellschaft (SARTF) Q2 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q2 2023 Earnings Conference Call July 21, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - Chairman of the Executive Board and Chief Executive Office...

Sartorius: A German Champion With A Discounted Price
Sartorius has been experiencing a demand decline since 2022. Sartorius serves a niche market, which gives it a strong moat. Sartorius benefits from the long-term tailwinds of its sector.

Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript.

Sartorius, Sartorius Stedim shares fall after Polyplus acquisition
Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA DIM, -6.51% fell in opening trade on Friday after the compan...

Sartorius AG: Combating And Benefiting From Eroom's Law
Sartorius is a low volume, almost private business, but offers investors exposure to great fundamentals in healthcare. With qualities that separate them from larger peers, Sartorius may offer a better...

Sartorius Aktiengesellschaft (SARTF) Q4 2022 Earnings Call Transcript
Sartorius Aktiengesellschaft (OTCPK:SARTF) Q4 2022 Earnings Conference Call January 26, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - Chairman of Exec. Board & CEO Rainer Lehmann - CFO, Mem...